169 related articles for article (PubMed ID: 23921441)
1. The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family.
MacCarthy CM; Notario V
Int J Oncol; 2013 Oct; 43(4):1244-52. PubMed ID: 23921441
[TBL] [Abstract][Full Text] [Related]
2. Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene.
Páez JG; Recio JA; Rouzaut A; Notario V
Int J Oncol; 2001 Dec; 19(6):1249-54. PubMed ID: 11713596
[TBL] [Abstract][Full Text] [Related]
3. NTPDase5/PCPH as a new target in highly aggressive tumors: a systematic review.
Bracco PA; Bertoni AP; Wink MR
Biomed Res Int; 2014; 2014():123010. PubMed ID: 25045656
[TBL] [Abstract][Full Text] [Related]
4. PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
Villar J; Quadri HS; Song I; Tomita Y; Tirado OM; Notario V
Cancer Res; 2009 Jan; 69(1):102-10. PubMed ID: 19117992
[TBL] [Abstract][Full Text] [Related]
5. Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1.
Recio JA; Páez JG; Maskeri B; Loveland M; Velasco JA; Notario V
Cancer Res; 2000 Mar; 60(6):1720-8. PubMed ID: 10749145
[TBL] [Abstract][Full Text] [Related]
6. Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein.
Recio JA; Páez JG; Sanders S; Kawakami T; Notario V
Cancer Res; 2002 May; 62(9):2690-4. PubMed ID: 11980669
[TBL] [Abstract][Full Text] [Related]
7. PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism.
Villar J; Arenas MI; MacCarthy CM; Blánquez MJ; Tirado OM; Notario V
Cancer Res; 2007 Nov; 67(22):10859-68. PubMed ID: 18006831
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest.
Read R; Hansen G; Kramer J; Finch R; Li L; Vogel P
Vet Pathol; 2009 May; 46(3):491-504. PubMed ID: 19176496
[TBL] [Abstract][Full Text] [Related]
9. Characterization of E-NTPDase (EC 3.6.1.5) activity in hepatic lymphocytes: A different activity profile from peripheral lymphocytes.
Doleski PH; Adefegha SA; Cabral FL; Leal DB
Cell Biochem Funct; 2017 Mar; 35(2):105-112. PubMed ID: 28217922
[TBL] [Abstract][Full Text] [Related]
10. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
11. Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines.
Rouzaut A; Recio JA; Notario V
Radiat Res; 2001 Jan; 155(1 Pt 2):181-187. PubMed ID: 11121232
[TBL] [Abstract][Full Text] [Related]
12. Genomic-independent action of thyroid hormones on NTPDase activities in Sertoli cell cultures from congenital hypothyroid rats.
Zamoner A; Bruno AN; Casali EA; Corbelini PF; Diniz GP; Barreto-Chaves ML; Silva FR; Sarkis JJ; Pessoa-Pureur R
Life Sci; 2006 Dec; 80(1):51-8. PubMed ID: 16978660
[TBL] [Abstract][Full Text] [Related]
13. ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.
Zadran S; Amighi A; Otiniano E; Wong K; Zadran H
Tumour Biol; 2012 Dec; 33(6):2411-21. PubMed ID: 22992974
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of the PCPH proto-oncogene in rat mammary tumors induced with 7,12-dimethylbenz[a]anthracene.
Solanas M; Escrich E; Rouzaut A; Costa I; Martínez A; Notario V
Mol Carcinog; 2002 Apr; 33(4):219-27. PubMed ID: 11933075
[TBL] [Abstract][Full Text] [Related]
15. Expression of ecto-nucleoside triphosphate diphosphohydrolase1-3 (NTPDase1-3) by cortical astrocytes after exposure to pro-inflammatory factors in vitro.
Brisevac D; Bajic A; Bjelobaba I; Milosevic M; Stojiljkovic M; Beyer C; Clarner T; Kipp M; Nedeljkovic N
J Mol Neurosci; 2013 Nov; 51(3):871-9. PubMed ID: 23990338
[TBL] [Abstract][Full Text] [Related]
16. cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression.
Liao H; Hyman MC; Baek AE; Fukase K; Pinsky DJ
J Biol Chem; 2010 May; 285(19):14791-805. PubMed ID: 20178980
[TBL] [Abstract][Full Text] [Related]
17. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
[TBL] [Abstract][Full Text] [Related]
18. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
19. The ATP/ADP substrate specificity switch between Toxoplasma gondii NTPDase1 and NTPDase3 is caused by an altered mode of binding of the substrate base.
Krug U; Totzauer R; Zebisch M; Sträter N
Chembiochem; 2013 Nov; 14(17):2292-300. PubMed ID: 24115522
[TBL] [Abstract][Full Text] [Related]
20. [Ecto-nucleotidases of ectonucleoside triphosphate diphosphohydrolase family: structure, localization and functional significance].
Iablons'ka SV; Rybal'chenko VK
Ukr Biokhim Zh (1999); 2010; 82(3):5-17. PubMed ID: 21328873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
